New Cancer Medication Offers Hope For HER2-Positive Patients Who Failed Other Treatments

Enhertu was approved for the treatment of adults with HER2-positive breast cancer, that was either unable to be removed with surgery, had already spread to other parts of the both, or to patients who had received two or more treatments specific to HER2-positive breast cancer.

Source: Forbes.com Healthcare News - December 23, 2019 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news